(…) Three months ago the world’s first cosmetic stem-cell facelift was carried out on Pauline Wills, 55, an office manager from South London, by Dr Aamer Khan from the Harley Street Medical Skin Clinic. It cost £7,500, took nearly six hours under local anaesthetic and Pauline had the added bonus of losing an inch from her tummy.
And because the procedure uses the body’s own stem cells – which makes it a living tissue graft – you grow into your own facelift during the six months afterwards (…)
Stem cells are present throughout the body and one of their functions is
The Jumonjd3 protein is a sort of nervous system regulator, allowing stem cells to become neural cells. Researchers from the IFOM-IEO Campus of the European Institute of Oncology (EIO) in Milan, whose studies were published in Plos One magazine discovered the regulator protein. The researchers explained that the protein is an enzyme capable of activating the stem cell genes necessary to differentiate a cell into a nervous system cell.
The result, underlined the scientists led by Giusepe Testa, “adds an important perspective to understanding the intricate mechanisms of stem cell function.” This protein could soon become “a target to improve
Parkinson’s Disease – Medical world has struggled in finding permanent cure for this condition that usually affects men over the age of 50 years, but now this maybe changing with the advent of stem cell based research in regenerative medicine. A significant clinical human trial using these technique now seems feasible in the near future.
Stem Cells and its Potential:
Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish
Image by Associazione Luca Coscioni via Flickr
Stem cells are providing more than just hope against diabetes. The first patients treated with adult stem cells are no longer taking anti-diabetic drugs, while ‘extraordinary results have been obtained in mice with embryonic stem cells,’ said Senator Ignazio Marino yesterday in Rome at the Changing Diabetes Barometer forum.
‘Embryonic stem cells are something that we must keep in mind,’ said Marino referring to the first encouraging results obtained in the United States, where last year, the first data on the possibility of controlling diabetes in mice was published as well as the
What might become the first drug derived from human stem cells failed in two late-stage clinical trials, dealing a setback to the drug’s developer and to the stem cell field (…)
Prochymal is a preparation of mesenchymal stem cells, which are obtained from the bone marrow of healthy young adults.
Because the cells are derived from adults, they sidestep the ethical issues stemming from the destruction of human embryos needed to make embryonic stem cells. Unlike most other types of adult stem cells, mesenchymal cells grow well in culture, so thousands of doses can be produced from a single donation.